TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Increasing Infant Preventive Health Service Delivery in an Inner City Population
Brief Summary: The study hypothesis is that case management using patient navigators ("promatoras" in the Latino community) will increase infant immunization rates and use of well child care in an inner city population of low socioeconomic status.


Options:
A: Arm Label: Historical Cohort; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reminder Recall Outreach; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reminder-Recall-Outreach | Arm Label: Case Management; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Case Management | Arm Label: Patient Navigation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient Navigator | Intervention Type: BEHAVIORAL; Name: Reminder-Recall-Outreach; Assigned to Arm(s): Reminder Recall Outreach | Intervention Type: BEHAVIORAL; Name: Case Management; Assigned to Arm(s): Case Management | Intervention Type: BEHAVIORAL; Name: Patient Navigator; Assigned to Arm(s): Patient Navigation
B: Arm Label: Conditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Conditional Cash Transfer, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Unconditional Cash Transfer; Type: EXPERIMENTAL; Interventions: Other: Unconditional Cash Transfers, Other: Standard Agricultural Package, Other: Parenting Skills Classes | Arm Label: Control; Type: OTHER; Interventions: Other: Standard Agricultural Package, Other: Parenting Skills Classes | Intervention Type: OTHER; Name: Conditional Cash Transfer; Assigned to Arm(s): Conditional Cash Transfer | Intervention Type: OTHER; Name: Unconditional Cash Transfers; Assigned to Arm(s): Unconditional Cash Transfer | Intervention Type: OTHER; Name: Standard Agricultural Package; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer | Intervention Type: OTHER; Name: Parenting Skills Classes; Assigned to Arm(s): Conditional Cash Transfer, Control, Unconditional Cash Transfer
C: Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): N/A
D: Arm Label: No reminder / recall notice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mailed reminder / recall notice; Type: EXPERIMENTAL; Interventions: Behavioral: Childhood vaccination reminder / recall notification | Intervention Type: BEHAVIORAL; Name: Childhood vaccination reminder / recall notification; Assigned to Arm(s): mailed reminder / recall notice

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TIPS (With Coated Stents) OR PARACENTESIS + ALBUMIN ADMINISTRATION FOR THE TREATMENT OF REFRACTORY ASCITES IN PATIENTS WITH CIRRHOSIS : A RANDOMIZED TRIAL COMPARING SURVIVAL, QUALITY OF LIFE AND NUTRITIONAL STATUS
Brief Summary: The main end point of the study is to assess survival in cirrhotic patients with refractory ascites treated by TIPS (using PTFE covered stents) vs patients treated by paracentesis + albumin infusion.


Options:
A: Arm Label: Standard medical therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard medical therapy | Arm Label: Midodrine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard medical therapy, Drug: Midodrine | Arm Label: Tolvaptan group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard medical therapy, Drug: Tolvaptan | Arm Label: Tolvaptan plus midodrine arm; Type: EXPERIMENTAL; Interventions: Drug: Standard medical therapy, Drug: Tolvaptan, Drug: Midodrine | Intervention Type: DRUG; Name: Standard medical therapy; Assigned to Arm(s): Midodrine group, Standard medical therapy, Tolvaptan group, Tolvaptan plus midodrine arm | Intervention Type: DRUG; Name: Tolvaptan; Assigned to Arm(s): Tolvaptan group, Tolvaptan plus midodrine arm | Intervention Type: DRUG; Name: Midodrine; Assigned to Arm(s): Midodrine group, Tolvaptan plus midodrine arm
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: TIPS | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Paracenthese | Intervention Type: PROCEDURE; Name: TIPS; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Paracenthese; Assigned to Arm(s): 2
C: Arm Label: Standard medical treatment plus albumin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Diuretics plus human albumin | Arm Label: Standard medical treatment; Type: OTHER; Interventions: Drug: Diuretics (standard medical treatment) | Intervention Type: DRUG; Name: Diuretics plus human albumin; Assigned to Arm(s): Standard medical treatment plus albumin | Intervention Type: DRUG; Name: Diuretics (standard medical treatment); Assigned to Arm(s): Standard medical treatment
D: Arm Label: Albumin plus midodrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: albumin, Drug: Midodrine | Arm Label: salin solution plus pills; Type: PLACEBO_COMPARATOR; Interventions: Drug: albumin, Drug: Placebo | Intervention Type: DRUG; Name: albumin; Assigned to Arm(s): Albumin plus midodrine, salin solution plus pills | Intervention Type: DRUG; Name: Midodrine; Assigned to Arm(s): Albumin plus midodrine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): salin solution plus pills

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Early Intervention Prevent Developmental Disturbances/Delays and Improve the Health of Children Born Prematurely
Brief Summary: The purpose of this study is to examine whether an early intervention program may improve cognitive and behavioral short and longterm outcome in preterm infants.


Options:
A: Arm Label: Phase 1: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Phase 1: Facilitated infant care; Type: EXPERIMENTAL; Interventions: Behavioral: Family Nurture Intervention | Arm Label: Phase 2: Effectiveness; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Family Nurture Intervention | Intervention Type: BEHAVIORAL; Name: Family Nurture Intervention; Assigned to Arm(s): Phase 1: Facilitated infant care, Phase 2: Effectiveness
B: Intervention Type: BEHAVIORAL; Name: Sensitizing parents; Assigned to Arm(s): N/A
C: Arm Label: Hospital-Home; Type: EXPERIMENTAL; Interventions: Other: Interdisciplinary hospital-home intervention | Arm Label: Control Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Convencional treatment | Intervention Type: OTHER; Name: Interdisciplinary hospital-home intervention; Assigned to Arm(s): Hospital-Home | Intervention Type: OTHER; Name: Convencional treatment; Assigned to Arm(s): Control Intervention
D: Arm Label: Stockholm Preterm Interaction-Based Intervention (SPIBI); Type: EXPERIMENTAL; Interventions: Behavioral: Stockholm Preterm Interaction-Based Intervention (SPIBI) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stockholm Preterm Interaction-Based Intervention (SPIBI); Assigned to Arm(s): Stockholm Preterm Interaction-Based Intervention (SPIBI)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Early Intervention Prevent Developmental Disturbances/Delays and Improve the Health of Children Born Prematurely
Brief Summary: The purpose of this study is to examine whether an early intervention program may improve cognitive and behavioral short and longterm outcome in preterm infants.


Options:
A: Arm Label: Individually customized physiotherapy; Type: OTHER; Interventions: Other: Individually customized physiotherapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Individually customized physiotherapy; Assigned to Arm(s): Individually customized physiotherapy
B: Intervention Type: BEHAVIORAL; Name: Sensitizing parents; Assigned to Arm(s): N/A
C: Arm Label: CareToy; Type: EXPERIMENTAL; Interventions: Device: CareToy | Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard Care | Intervention Type: DEVICE; Name: CareToy; Assigned to Arm(s): CareToy | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
D: Arm Label: Term group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Usual care program group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Clinic-based interveniton program group; Type: EXPERIMENTAL; Interventions: Behavioral: clinic-based intervention program and home-based intervention program | Arm Label: Home-based interveniton program group; Type: EXPERIMENTAL; Interventions: Behavioral: clinic-based intervention program and home-based intervention program | Intervention Type: BEHAVIORAL; Name: clinic-based intervention program and home-based intervention program; Assigned to Arm(s): Clinic-based interveniton program group, Home-based interveniton program group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder
Brief Summary: This study examines the effect of Depakote ER versus placebo in a randomized trial of borderline personality disorder. Patients all participate in DBT therapy and those who are not responsive are assigned to either Depakote ER or placebo for up to 12 weeks. Borderline Personality Symtoms are measured and side-effects are assessed.


Options:
A: Intervention Type: DRUG; Name: Depakote ER; Assigned to Arm(s): N/A
B: Arm Label: MBT therapy plus treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Mentalization-Based Group Therapy for Adolescents | Arm Label: Treatment as usual alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mentalization-Based Group Therapy for Adolescents; Assigned to Arm(s): MBT therapy plus treatment as usual
C: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: Behavioral: Dialectical Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Cognitive Therapy; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder
Brief Summary: This study examines the effect of Depakote ER versus placebo in a randomized trial of borderline personality disorder. Patients all participate in DBT therapy and those who are not responsive are assigned to either Depakote ER or placebo for up to 12 weeks. Borderline Personality Symtoms are measured and side-effects are assessed.


Options:
A: Arm Label: Inpatient Adaptation of DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Inpatient Adaptation of DBT | Arm Label: Outpatient DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: standard outpatient DBT | Intervention Type: BEHAVIORAL; Name: standard outpatient DBT; Assigned to Arm(s): Outpatient DBT | Intervention Type: BEHAVIORAL; Name: Inpatient Adaptation of DBT; Assigned to Arm(s): Inpatient Adaptation of DBT
B: Intervention Type: DRUG; Name: Depakote ER; Assigned to Arm(s): N/A
C: Arm Label: Brief Admission; Type: EXPERIMENTAL; Interventions: Other: Brief Admission | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Brief Admission; Assigned to Arm(s): Brief Admission
D: Arm Label: 1; Type: OTHER; Interventions: Drug: Naltrexone | Arm Label: 2; Type: OTHER; Interventions: Drug: Naltrexone | Arm Label: 3; Type: OTHER; Interventions: Drug: Naltrexone | Arm Label: 4; Type: OTHER; Interventions: Drug: Naltrexone | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): 1, 2, 3, 4

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Deworming and Enhanced Vitamin A Supplementation DEVTA Project
Brief Summary: Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.


Options:
A: Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Vitamin + Zinc + micronutrient mixture; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Vitamin A + Zinc; Assigned to Arm(s): N/A
C: Arm Label: a; Type: EXPERIMENTAL; Interventions: Drug: Glutamine | Arm Label: b; Type: EXPERIMENTAL; Interventions: Drug: Vitamin A, Drug: zinc | Arm Label: c; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin A, Drug: zinc | Arm Label: d; Type: PLACEBO_COMPARATOR; Interventions: Drug: glycine | Arm Label: e; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vitamin A, Drug: zinc | Arm Label: f; Type: EXPERIMENTAL; Interventions: Drug: Vitamin A, Drug: zinc | Intervention Type: DRUG; Name: Glutamine; Assigned to Arm(s): a | Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): b, c, e, f | Intervention Type: DRUG; Name: glycine; Assigned to Arm(s): d | Intervention Type: DRUG; Name: zinc; Assigned to Arm(s): b, c, e, f
D: Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Deworming and Enhanced Vitamin A Supplementation DEVTA Project
Brief Summary: Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.


Options:
A: Arm Label: Hand hygiene; Type: EXPERIMENTAL; Interventions: Behavioral: Hand washing with soap and hand finger nail clipping | Arm Label: Hand finger nail hygiene; Type: EXPERIMENTAL; Interventions: Behavioral: Hand washing with soap and hand finger nail clipping | Arm Label: Hand and finger nails hygiene; Type: EXPERIMENTAL; Interventions: Behavioral: Hand washing with soap and hand finger nail clipping | Arm Label: Customary practice; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Hand washing with soap and hand finger nail clipping | Intervention Type: BEHAVIORAL; Name: Hand washing with soap and hand finger nail clipping; Assigned to Arm(s): Customary practice, Hand and finger nails hygiene, Hand finger nail hygiene, Hand hygiene
B: Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Sanitation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sanitation; Assigned to Arm(s): Intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Shoes; Type: EXPERIMENTAL; Interventions: Device: Shoes | Intervention Type: DEVICE; Name: Shoes; Assigned to Arm(s): Shoes

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Deworming and Enhanced Vitamin A Supplementation DEVTA Project
Brief Summary: Randomisation of 72 large rural areas ("blocks") into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.


Options:
A: Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): N/A
B: Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A; Assigned to Arm(s): N/A
C: N/A
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: vitamin A supplement; Type: ACTIVE_COMPARATOR; Interventions: Drug: vitamin A supplements | Intervention Type: DRUG; Name: vitamin A supplements; Assigned to Arm(s): vitamin A supplement | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clopidogrel Or Metoprolol in Myocardial Infarction Trial
Brief Summary: COMMIT/CCS2 is a large randomised trial of the effects of clopidogrel plus Aspirin versus Aspirin alone in acute heart disease. Patients presenting within 24 hours of the onset of suspected acute MI were potentially eligible provided they were thought to have ST elevation or other ischaemic ECG abnormality with no clear indication for, or contraindication to, trial treatment. All patients were to be given 162 mg ASA daily and, in addition, 75 mg clopidogrel daily or matching placebo for 4 weeks or until prior discharge or death. (Patients were also randomised separately in a 2 X 2 factorial design between metoprolol versus placebo.) The two main study endpoints are death and the composite outcome of death, non-fatal reinfarction or stroke during the scheduled treatment period in hospital.


Options:
A: Arm Label: Beta-blocker adherence after an AMI; Type: EXPERIMENTAL; Interventions: Behavioral: Beta-blocker adherence after an AMI | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Beta-blocker adherence after an AMI; Assigned to Arm(s): Beta-blocker adherence after an AMI
B: Intervention Type: DRUG; Name: clopidogrel and metoprolol; Assigned to Arm(s): N/A
C: Arm Label: Beta-blocker; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carvedilol | Arm Label: Non Beta-blocker; Type: ACTIVE_COMPARATOR; Interventions: Drug: No Carvedilol | Intervention Type: DRUG; Name: Carvedilol; Assigned to Arm(s): Beta-blocker | Intervention Type: DRUG; Name: No Carvedilol; Assigned to Arm(s): Non Beta-blocker
D: Intervention Type: DRUG; Name: clopidogrel (SR25990); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clopidogrel Or Metoprolol in Myocardial Infarction Trial
Brief Summary: COMMIT/CCS2 is a large randomised trial of the effects of clopidogrel plus Aspirin versus Aspirin alone in acute heart disease. Patients presenting within 24 hours of the onset of suspected acute MI were potentially eligible provided they were thought to have ST elevation or other ischaemic ECG abnormality with no clear indication for, or contraindication to, trial treatment. All patients were to be given 162 mg ASA daily and, in addition, 75 mg clopidogrel daily or matching placebo for 4 weeks or until prior discharge or death. (Patients were also randomised separately in a 2 X 2 factorial design between metoprolol versus placebo.) The two main study endpoints are death and the composite outcome of death, non-fatal reinfarction or stroke during the scheduled treatment period in hospital.


Options:
A: Arm Label: aspirin low responders monotherapy; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: aspirin low responders dual antiplatelet therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): aspirin low responders dual antiplatelet therapy
B: Intervention Type: DRUG; Name: clopidogrel and metoprolol; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin Tablets | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel (over encapsulated) capsule, Drug: Aspirin Tablets | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Ticagrelor Tablets, Drug: Aspirin Tablets | Intervention Type: DRUG; Name: Ticagrelor Tablets; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Clopidogrel (over encapsulated) capsule; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Aspirin Tablets; Assigned to Arm(s): 1, 2, 3
D: Arm Label: Combination therapy; Type: EXPERIMENTAL; Interventions: Drug: Clopidogrel, Drug: Aspirin | Arm Label: Monotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel placebo, Drug: Aspirin | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Combination therapy | Intervention Type: DRUG; Name: Clopidogrel placebo; Assigned to Arm(s): Monotherapy | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): Combination therapy, Monotherapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clopidogrel Or Metoprolol in Myocardial Infarction Trial
Brief Summary: COMMIT/CCS2 is a large randomised trial of the effects of clopidogrel plus Aspirin versus Aspirin alone in acute heart disease. Patients presenting within 24 hours of the onset of suspected acute MI were potentially eligible provided they were thought to have ST elevation or other ischaemic ECG abnormality with no clear indication for, or contraindication to, trial treatment. All patients were to be given 162 mg ASA daily and, in addition, 75 mg clopidogrel daily or matching placebo for 4 weeks or until prior discharge or death. (Patients were also randomised separately in a 2 X 2 factorial design between metoprolol versus placebo.) The two main study endpoints are death and the composite outcome of death, non-fatal reinfarction or stroke during the scheduled treatment period in hospital.


Options:
A: Intervention Type: DRUG; Name: clopidogrel and metoprolol; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: N/A; Interventions: Other: Blood sample | Intervention Type: OTHER; Name: Blood sample; Assigned to Arm(s): 1
C: Arm Label: Early metoprolol initiation strategy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Injectable (i.v.) metoprolol tartrate (up to 15 mg). | Arm Label: Delayed metoprolol initiation strategy; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Injectable (i.v.) metoprolol tartrate (up to 15 mg).; Assigned to Arm(s): Early metoprolol initiation strategy
D: Arm Label: Beta-blocker; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carvedilol | Arm Label: Non Beta-blocker; Type: ACTIVE_COMPARATOR; Interventions: Drug: No Carvedilol | Intervention Type: DRUG; Name: Carvedilol; Assigned to Arm(s): Beta-blocker | Intervention Type: DRUG; Name: No Carvedilol; Assigned to Arm(s): Non Beta-blocker

Answer: A